表皮生长因子受体在促进妊娠糖尿病中内皮细胞功能障碍的机制
Dan Tang1, Cheng-Fen Wang2, Jue Wang3
1Department of Obstetrics, The First Affiliated Hospital of Kunming Medical University, Kunming 650032, Yunnan Province, China.
表皮生长因子受体 (EGFR) 通过促进内皮功能障碍,加剧妊娠糖尿病 (GDM). 向EGFR可能为GDM并发症提供治疗策略.
科学领域:
- 内分泌学和新陈代谢学
- 分子生物学分子生物学
- 血管生物学 血管生物学
背景情况:
- 孕期糖尿病 (GDM) 与内皮功能障碍有关,这是一个关键的病理特征.
- 表皮生长因子受体 (EGFR) 在各种疾病中与内皮功能障碍有关.
- 在GDM诱导的内皮功能障碍中EGFR的确切作用和调节尚不清楚.
研究的目的:
- 阐明EGFR对GDM内皮细胞功能障碍的分子机制.
- 在GDM的背景下,研究EGFR的转录和蛋白质水平调节.
主要方法:
- 定量实时PCR测量EGFR和H19表达.
- 西部血栓检查,以评估内皮功能障碍标志物.
- 细胞活力,细胞亡,迁移和血管形成试验 (CCK-8,流细胞计,划痕,Transwell,管形成).
- 在GDM小鼠模型中对胎盘组织的组织病理学分析.
主要成果:
- 在GDM临床样本和模型中,EGFR被上调.
- 抑制EGFR减轻了GDM的影响,促进了内皮细胞的增殖,迁移,血管化,并抑制了细胞亡.
- 在体内,EGFR knockdown 降低了内皮功能障碍的标志物 (VCAM-1,TNF-α,VEGF-A,ICAM-1) 和减轻了GDM表型.
- 从机制上讲,EIF4A3-H19相互作用稳定了EGFRmRNA,促进了功能障碍;ERRFI1抑制了EGFR活动.
结论:
- 通过加剧内皮细胞功能障碍,EGFR加速了GDM的发展.
- 针对EGFR途径为GDM提供了潜在的治疗途径.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
相关概念视频
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Regulation of Angiogenesis and Blood Supply
Mitogens and the Cell Cycle
Cell Specific Gene Expression
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
